Clearmind Medicine Statistics
Total Valuation
CMND has a market cap or net worth of $2.10 million. The enterprise value is -$1.71 million.
Important Dates
The next estimated earnings date is Thursday, March 12, 2026, after market close.
| Earnings Date | Mar 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CMND has 1.79 million shares outstanding. The number of shares has increased by 63.99% in one year.
| Current Share Class | 1.79M |
| Shares Outstanding | 1.79M |
| Shares Change (YoY) | +63.99% |
| Shares Change (QoQ) | +2.41% |
| Owned by Insiders (%) | 13.70% |
| Owned by Institutions (%) | 0.41% |
| Float | 1.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.16 |
| P/TBV Ratio | 1.92 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.22, with a Debt / Equity ratio of 1.49.
| Current Ratio | 1.22 |
| Quick Ratio | 1.21 |
| Debt / Equity | 1.49 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -290.07 |
Financial Efficiency
Return on equity (ROE) is -179.39% and return on invested capital (ROIC) is -115.52%.
| Return on Equity (ROE) | -179.39% |
| Return on Assets (ROA) | -53.11% |
| Return on Invested Capital (ROIC) | -115.52% |
| Return on Capital Employed (ROCE) | -475.20% |
| Weighted Average Cost of Capital (WACC) | -0.64% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CMND has paid $70,445 in taxes.
| Income Tax | 70,445 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -97.80% in the last 52 weeks. The beta is -1.12, so CMND's price volatility has been lower than the market average.
| Beta (5Y) | -1.12 |
| 52-Week Price Change | -97.80% |
| 50-Day Moving Average | 2.26 |
| 200-Day Moving Average | 26.88 |
| Relative Strength Index (RSI) | 25.33 |
| Average Volume (20 Days) | 449,911 |
Short Selling Information
The latest short interest is 29,379, so 1.64% of the outstanding shares have been sold short.
| Short Interest | 29,379 |
| Short Previous Month | 100,877 |
| Short % of Shares Out | 1.64% |
| Short % of Float | 2.10% |
| Short Ratio (days to cover) | 0.24 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -5.67M |
| Pretax Income | -3.79M |
| Net Income | -3.86M |
| EBITDA | -5.66M |
| EBIT | -5.67M |
| Earnings Per Share (EPS) | -$30.35 |
Full Income StatementBalance Sheet
The company has $5.59 million in cash and $1.78 million in debt, with a net cash position of $3.81 million or $2.12 per share.
| Cash & Cash Equivalents | 5.59M |
| Total Debt | 1.78M |
| Net Cash | 3.81M |
| Net Cash Per Share | $2.12 |
| Equity (Book Value) | 1.19M |
| Book Value Per Share | 7.54 |
| Working Capital | 1.06M |
Full Balance SheetCash Flow
| Operating Cash Flow | -4.73M |
| Capital Expenditures | n/a |
| Free Cash Flow | -4.73M |
| FCF Per Share | -$2.64 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
